Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Cureus ; 15(7): e41591, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37559849

ABSTRACT

We present the first documented case of metastatic melanoma to the orbit with dedifferentiation. A patient with a history of melanoma of the lip and other poorly differentiated carcinomas presented with both a sub-brow and an intraorbital mass. Radiographically and intraoperatively, the sub-brow mass communicated with the intraorbital mass via perineural spread along the supraorbital nerve. Histopathology confirmed the diagnosis of melanoma based on the melanocytic markers, SOX-10 and Melan-A; dedifferentiation was demonstrated within the orbital tumor. Two weeks following surgical debulking, the intraorbital mass returned to its full size. Local radiotherapy and immunotherapy were performed, which initially led to a dramatic improvement; however, the patient succumbed to his systemic metastases six months later. Dedifferentiation serves as a prognostic indicator and should be considered in patients when histopathology does not lead to a definitive diagnosis.

2.
Ophthalmic Plast Reconstr Surg ; 39(6): 525-532, 2023.
Article in English | MEDLINE | ID: mdl-37010053

ABSTRACT

PURPOSE: The oculofacial plastic surgeon will more frequently encounter challenges related to overweight and obese patients as the incidence rises. There is a paucity of data in the oculofacial plastic surgical literature regarding this topic. The goal of this review is to detail the role obesity plays in the perioperative course and the considerations for a surgeon treating this patient population. METHODS: The authors conducted a computerized search using PubMed, Embase, and Google Scholar. The search terms used were "(obesity OR overweight) AND surgery," "(obesity OR overweight) AND oculoplastic," "(obesity OR overweight) AND oculofacial," "(obesity OR overweight) AND 'facial plastic surgery', " "(obesity OR overweight) AND 'bariatric surgery', " "(obesity OR overweight) AND (pre-operative OR post-operative OR intraoperative," " (obesity OR overweight) AND complications," "(obesity OR overweight) AND (facial plastic surgery) AND complications)," "(obesity OR overweight) AND eyelid," "(obesity OR overweight) AND (nasolacrimal OR 'nasolacrimal duct')," "(obesity OR overweight) AND IIH," "(obesity OR overweight) AND exophthalmos." RESULTS: A total of 127 articles, published from 1952 to 2022 in the English language or with English translations were included. Articles published earlier than 2000 were cited for foundational knowledge. References cited in the identified articles were also used to gather further data for the review. CONCLUSIONS: Overweight and obese patients pose specific challenges that the oculofacial plastic surgeon should be aware of to better optimize patient outcomes. Multiple comorbidities, poor wound healing, and nutritional deficits all contribute to the complications experienced in this patient population. Further investigation on overweight and obese patients is needed.


Subject(s)
Plastic Surgery Procedures , Surgery, Plastic , Humans , Overweight/complications , Overweight/surgery , Obesity/complications , Obesity/surgery , Comorbidity
3.
Digit J Ophthalmol ; 29(4): 97-1000, 2023.
Article in English | MEDLINE | ID: mdl-38344060

ABSTRACT

Crocodile tear syndrome (CTS) is a late complication of facial nerve palsy characterized by unilateral lacrimation in response to gustatory stimulation. We present 2 cases of patients diagnosed with CTS after recovering from unilateral idiopathic facial nerve palsy. Both patients underwent transconjunctival lacrimal gland incobotulinumtoxinA injection, with doses of 5-16 units. The patients were seen in clinic for post-treatment follow-up at 2 weeks, 3 months, and 6 months. Outcomes were measured by treatment efficacy and adverse drug effects. Following treatment, both patients reported resolution of gustatory lacrimation. The patient treated with 16 U experienced transient ptosis and diplopia following injection, whereas the patient treated with 5-7.5 U experienced no adverse effects.


Subject(s)
Autonomic Nervous System Diseases , Bell Palsy , Blepharoptosis , Botulinum Toxins, Type A , Congenital Cranial Dysinnervation Disorders , Facial Paralysis , Jaw Abnormalities , Lacrimal Apparatus Diseases , Lacrimal Apparatus , Neuromuscular Agents , Reflex, Abnormal , Toxins, Biological , Humans , Lacrimal Apparatus/innervation , Botulinum Toxins, Type A/pharmacology , Botulinum Toxins, Type A/therapeutic use , Neuromuscular Agents/pharmacology , Neuromuscular Agents/therapeutic use , Lacrimal Apparatus Diseases/diagnosis , Lacrimal Apparatus Diseases/drug therapy , Facial Paralysis/complications , Facial Paralysis/drug therapy , Bell Palsy/complications , Bell Palsy/drug therapy , Autonomic Nervous System Diseases/complications , Autonomic Nervous System Diseases/drug therapy , Toxins, Biological/pharmacology , Toxins, Biological/therapeutic use
4.
Ocul Surf ; 24: 67-73, 2022 04.
Article in English | MEDLINE | ID: mdl-35167950

ABSTRACT

Ocular surface disease (OSD) in the setting of thyroid eye disease (TED) is traditionally thought of as a natural consequence of anatomical changes such as proptosis and corneal exposure. However, a growing body of research suggests that ocular surface inflammation and multi-factorial changes to the homeostasis of the ocular surface contribute substantially to the OSD seen in TED patients. In this paper we review the existing literature which highlights the work and existing theories underlying this new paradigm shift.


Subject(s)
Graves Ophthalmopathy , Eye , Humans
5.
Mil Med ; 186(7-8): e840-e842, 2021 07 01.
Article in English | MEDLINE | ID: mdl-33201244

ABSTRACT

Corneal injury is a known risk for deployed troops worldwide. To the authors' knowledge, there has been no reported use of gamma-irradiated corneas in the setting of severe corneal trauma. Our report highlights the case of a 36-year-old active duty solider who sustained bilateral penetrating ocular trauma from a nearby ordnance explosion. We propose that ocular surgeons should consider utilizing gamma-irradiated corneas in (1) a situation where the corneal tissue is so damaged that it would be challenging to accomplish an adequate repair while providing the opportunity for future visual rehabilitation and (2) remote and/or deployed environments where storage of fresh donor tissue is limited. The long shelf life of gamma-irradiated corneas reduces the need for specialized storage equipment and the need for continuous resupply, both potentially leading to significant cost savings for the Military Health System.


Subject(s)
Cornea , Eye Injuries , Adult , Gamma Rays , Humans , Tissue Donors
SELECTION OF CITATIONS
SEARCH DETAIL
...